Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer
-- Dr. De La Rosa adds over 20 years of big pharma and biotech infectious disease clinical trial experience to Curevo Vaccine Seattle, WA – April 11, 2023 – Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced Dr. Guy De La Rosa has…